| Prev Close: | 4.50 |
|---|---|
| Open: | 4.54 |
| Bid: | 4.25 x 100 |
| Ask: | 4.77 x 200 |
| 1y Target Est: | 8.88 |
| Beta: | 0.18 |
| Next Earnings Date: | 7-Aug-13 |
| Day's Range: | 4.41 - 4.62 |
|---|---|
| 52wk Range: | 0.21 - 4.62 |
| Volume: | 11,893 |
| Avg Vol (3m): | 44,479 |
| Market Cap: | 36.28M |
| P/E (ttm): | 45.00 |
| EPS (ttm): | 0.10 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- CHEMBIO DIAGNOSTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, FiEDGAR Online(Fri 5:27AM EDT)
- 4 Healthcare Stock Stories Prescribed For Investorsat Wall St. Cheat Sheet(Thu, May 23)
- InPlay: Chembio awarded $750,000 cooperative research agreementBriefing.com(Thu, May 23)
- Chembio Awarded $750,000 Cooperative Research AgreementGlobeNewswire(Thu, May 23)
- Chembio Appoints Sharon Klugewicz as Chief Operating OfficerGlobeNewswire(Wed, May 22)
- Chembio Enters International Distribution and Assembly Agreement With LabtestGlobeNewswire(Tue, May 21)
- CHEMBIO DIAGNOSTICS, INC. FinancialsEDGAR Online Financials(Fri, May 17)
- Chembio Sponsors 28th Annual AIDS Walk New York as Co-Chair AdvocateGlobeNewswire(Fri, May 17)
- CHEMBIO DIAGNOSTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online(Fri, May 17)
- Chembio Enters Into Six-Month Follow-On Contract With CDC Contractor for Development of Rapid, Point-of-Care Influenza Immunity TestGlobeNewswire(Thu, May 16)
- Chembio's DPP(R) HIV-Syphilis Multiplex Test Demonstrates 100% Sensitivity and Specificity in Evaluation by Mexico's Institute of Epidemiological Diagnosis and ReferenceGlobeNewswire(Tue, May 14)
- New Opportunities Could Offset FIOCRUZ SlowdownZacks Small Cap Research(Mon, May 13)
- Chembio Diagnostics Reports First Quarter 2013 Financial ResultsGlobeNewswire(Thu, May 9)
- Q1 2013 CHEMBIO DIAGNOSTICS INC Earnings Release - Before Market OpenCCBN(Thu, May 9)
- CHEMBIO DIAGNOSTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online(Thu, May 9)
Press Releases
- Chembio Awarded $750,000 Cooperative Research AgreementGlobeNewswire(Thu, May 23)
- Chembio Appoints Sharon Klugewicz as Chief Operating OfficerGlobeNewswire(Wed, May 22)
- Chembio Enters International Distribution and Assembly Agreement With LabtestGlobeNewswire(Tue, May 21)
Reports
- ValuEngine Industry Report for Medical ProductsValuEngine, Inc.(May 24)
- ValuEngine Detailed Valuation Report for CEMIValuEngine, Inc.(May 23)
- Wright Investors Service Comprehensive Report for Chembio Diagnostics, Inc.Wright Reports(May 1)